Algorithm: Sedation Protocol

Algorithm: Sedation Protocol

DVT and PE Pharamcotherapy TEACHING SLIDES Olavo Fernandes Pharm.D. Pharmacy Practice Leader, University Health Network Assistant Professor, University of Toronto October 2002 UHN Residency Open House Monday October 21st, 2002 5:30 pm to 8:00 pm Princess Margaret Hospital 610 University Ave 5th Floor Cafeteria The evening will include: An information session on our residency program

A question and answer period Tours of the department and the hospitals Food will be provided Please RSVP to Tamar / Nancy at 416-340-3611 By October 18th, 2002 DEFINTIONS DVT thrombus material composed of cellular material (RBC, WBC, Plts) bound together with fibrin strands forms in the venous portion of the vasculature

PE thrombus from from systemic circulation lodges in pulmonary artery or branches causing complete or partial obstruction of pulmonary blood flow 95% originate from DVT Submassive <50 % of pulmonary vascular bed occluded VTE= DVT + PE Massive <50 % of pulmonary vascular bed occluded EPIDEMIOLOGY DVT

48 per 100, 000 PE 69 per 100, 000 (with our without associated DVT) 100, 000 deaths annually due to PE Mortality (30% untreated; 8% with treatment ) PATHOPHYSIOLOGY Virchows Triangle abnormalities in blood blow (bed rest, tumour obstruction) abnormalities in clotting function (malignancy, pregnancy, deficiencies in Anti-thrombin III, Ptn S or C)

abnormal vascular surfaces (catheters, vascular injury, trauma) To form a clot: imbalance in triangle; activation of intrinsic and extrinsic pathway and cascade Venous Thrombi (red) Arterial Thrombi (white) RISK FACTORS for DVT surgery or trauma MI

stroke increasing age prior VTE estrogen use Factor V leiden Anti-phospholipid syndrome pregnancy CHF Cancer obesity

prolonged immobilization Smoking Ptn C or S or antithrombin deficiency HIT CLINICAL PRESENTATION DVT symptoms present when

obstruction of venous flow inflammation of vein wall or perivascular space embolization to lung unilateral leg pain leg tenderness leg swelling redness/ discolouration palpable cord venous distention Homan sign (calf pain on dorsiflexion of the foot) SILENT presentation PE

*transient dyspnea (84%) tachypnea (RR > 20) 85% +pleuritic chest pain (74%) *apprehension (63%) tachycardia (HR > 100) (58%) cough (50%) +hemoptysis (28%) *syncope (13%) hypoxemia, hypotension, cardiogenic shock *more often assoc with massive PE +more often assoc with submassive PE

SILENT presentation Endpoints: Outcome Assessment VTE endpoints Venography Duplex compression ultrasonography Impedance Plesmography Fibrinogen Uptake D-Dimer Testing PE (lung scanning, angiography, autopsy) Safety endpoints Major and minor bleeds Thrombocytopenia Mortality MANAGEMENT OPTIONS

DVT pharmacological agents surgery (rarely indicated) PE pharmacological agents thrombolytics surgery (endarterectomy, can be life saving, specialized centres) Greenfield Filters (px) THERAPEUTIC OPTIONS

Heparin LMWH Warfarin (oral) Danaparoid Hirudin/ Lepirudin Ancrod Thrombolytics (PE) Pentasacharide Injection (phase 3) Thrombin inhibitors (oral) (phase 3) Pharmacologic Agents

MOA Place in Therapy Dosing Monitoring Adverse Effects/ Limitations Reversal Agents HEPARIN reversal: protamine effective Unpredictable dose response requires monitoring complications: HIT,

platelets, bleeding long term target: 1.5 -2.5 x control osteoporosis onset: immediate does not inactivate advantage: can stop if clot bound thrombin bleeding (t 1/2 short) short MOA: binds to antithrombin III Monitor: aPTT - heparin inhibition of thrombin (IIa) and factors Xa and IXa LMWH MOA: preferentially

inhibit factor Xa Monitor: limited requirement ; antiXa for renal failure and obesity platelets, bleeding target: variable onset: immediate prolonged effectmore difficult to immediately reverse effect reversal: difficult : protamine OD vs. BID as effective, same incidence of bleeds/ mortality

wt based dosing UFH and LMWH Continue therapy for at least 5 days (Grade 1A) longer duration of UFH or LMWH if massive PE Should overlap with warfarin for at least 4-5 days. D/C after 2 consecutive days of therapeutic INR Favourable properties of a LMWH increased plasma half life- once daily/ bid dosing reduced non-specific binding to plasma proteins (predictable anticoagulant response, predictable bioavialability) reduced binding to platelets : (less HIT, potential for less bleeding) less need for monitoring/ SC outpatient option

less daily injections reduced binding to osteoblasts (less bone loss) Favourable properties of a LMWH less expensive short acting- desirable in patients at high risk of bleeding - can quickly reverse anticoagulation WARFARIN MOA: inhibits vit K dep coagn factors (II, VII, IX, X) Monitor: INR , bleeding target: 2-3 unless MVR onset: delayed clotting factor half lives (factor II 72 hrs) reversal: Vitamin K

Bleeding risk correlated to INR inc with INR > 4 major bleeds < 3% INR 2-3 Drug Interactions Duration of Warfarin Therapy Reversible or time limited RFs - first event (3-6 months) Idiopathic VTE- first event (> 6 months) 12 mos- lifetime first event with: cancer until resolved; antithrombin deficiency; anticardiolipin Ab recurrent event, idiopathic or with thrombophilia WARFARIN DRUG INTERACTIONS : Increased INR

TMP/ SMX inhibits hepatic metabolism of S-warfarin increases response to warfarin (even 3 day course) Amiodarone dramatic increase rough estimation - 50% decrease in therapeutic warfarin maintenance dose Metronidazole dramatic increase Acetaminophen interaction appears more likely at doses > 2000 mg/ day for a week or more

Ciprofloxacin case reports - monitor INR Fluconazole inc INR especially with doses > 200 mg/ day Phenytoin can both increase or decrease INR WARFARIN DRUG INTERACTIONS : Pharmacodynamic and dec. INR Pharmacodynamic ASA

NSAIDS clopidogrel, ticlopidine Decreased INR carbamazepine Binding resins barbituates WARFARIN COUNSELLING POINTS Indication How it works prevents abnormal clots; stop existing clots from getting larger, decreases risk of clot breaking off Blood Test Monitoring (INR) Administration

Length of Therapy Risks: bleeding (practical discussion) advise dentist Drug interactions Rx and Herbal Diet Alcohol Missed pills WARFARIN COUNSELLING POINTS When to contact MD: blood in urine, stool, persistent nose bleed, increased swelling in extremity

When to go to ER: SOB, Chest pain, coughing up blood, black tarry stools, severe HA of sudden onset, slurred speech Thrombolytics for PE Indicated only if massive PE, submassive with hemodynamic compromise (or failure of heparin tx) can start 7-14 days after PE dx only when dx certain (V/Q scan, angiography) only if no contraindications absolute (active bleed; CVA or neurosurg in last 10 days) relative (sx in last 10 days; severe HTN, pregnancy, GI bleed in last 3 months), arotic aneurysm, diabetic retinopathy, serious recent trauma bleeding risks expensive

Indications for Exoxaparin Non-ST segment elevation ACS angina at rest lasting at least 10 min evidence of underlying IHD - specific ECG changes inpatients Exclude: chest pain NYD, persistent ST segment elevation; emergency intervention within 24 hrs

Recently Viewed Presentations

  • CSE 403 Lecture Slides - University of Washington

    CSE 403 Lecture Slides - University of Washington

    Lecture 19 Reliability Testing slides created by Marty Stepp
  • Chapter 6-9 &quot;Industrialization, Immigration, Urbanization and ...

    Chapter 6-9 "Industrialization, Immigration, Urbanization and ...

    The Philippines became a U.S. possession, and the United States put down an independence movement there. It annexed Hawaii after white planters overthrew the native monarchy. In China, it applied its Open Door Policy to limit foreign control and maintain...
  • Escala niveles de participación (Schofield y Thoburn)

    Escala niveles de participación (Schofield y Thoburn)

    Times New Roman Arial Calibri Diseño predeterminado Presentación de PowerPoint Derecho del niño a participar en las decisiones que afectan su vida Participación del niño en el proceso: importancia y consecuencias Opinión del niño e interés sup. del niño Algunos...
  • Draft - OALM 2013 PPT Template - choice 1

    Draft - OALM 2013 PPT Template - choice 1

    Hruta Virkar, Chief. Resolves Single Audit & OIG Audit Findings. Performs Financial Capability & Accounting System Reviews. Performs Cost Analysis. Negotiates IDC rates for non-SBIR/STTR grantees. SBIR / STTR Pilot. Negotiates IDC rates for all NIH grantees and contractors that...
  • colossians - Grace Bible Church of Pullman

    colossians - Grace Bible Church of Pullman

    The aorist tense gathers into one entirety every time that Epaphras taught and every time the Colossians listened and applied truth that he taught them. The pastor-teacher communicated and the Colossians responded. This is the correct function of a local...
  • Verbals and Verbal Phrases - Mrs. Olinger&#x27;s English Page

    Verbals and Verbal Phrases - Mrs. Olinger's English Page

    Verbals and Verbal Phrases!!AWESOME!! Verbal verb subject Adjective subject verb Gerund A verbal is a word that ends in ing and functions as a noun. This can be used as a: Subject Direct object Subject complement Object of the preposition...
  • Poetic Meter - Weebly

    Poetic Meter - Weebly

    Describing Poetic Meter •About Rich's poem, "Aunt Jennifer's Tigers," then, we could say that its meter is •iambic pentameter •This tells readers that the dominant meter of the poem is 5 stresses to a line (pentameter) and that the dominant...
  • Analyzing Arguments - Class Site for Ms. Fitzell-Stevens

    Analyzing Arguments - Class Site for Ms. Fitzell-Stevens

    From Claim to Thesis. Closed Thesis: statement of the main idea that also previews the major points the writer intends to make Beowulf is a true model of the Anglo Saxon hero because of his loyalty to his king and...